Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers
- 1 May 2001
- journal article
- Published by Elsevier BV in Osteoarthritis and Cartilage
- Vol. 9 (4), 289-293
- https://doi.org/10.1053/joca.2000.0387
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Radiographic assessment of hip and knee osteoarthritis. Recommendations: recommended guidelinesOsteoarthritis and Cartilage, 1999
- Clinical trials design: structure modifying agents for osteoarthritis. Future guidelines: areas for developmentOsteoarthritis and Cartilage, 1999
- Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with the osteoarthritis-related type II collagen gene COL2A1 mutationArthritis & Rheumatism, 1999
- Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society: Results from a workshopOsteoarthritis and Cartilage, 1996
- Recommendations for the registration of drugs used in the treatment of osteoarthritis. Group for the respect of ethics and excellence in science (GREES): osteoarthritis section.Annals Of The Rheumatic Diseases, 1996
- Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis.JCI Insight, 1994
- Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritisArthritis & Rheumatism, 1993
- Increased levels of proteoglycan fragments in knee joint fluid after injuryArthritis & Rheumatism, 1989
- Serum keratan sulfate levels in osteoarthritis patientsArthritis & Rheumatism, 1988
- Quantification of keratan sulfate in blood as a marker of cartilage catabolismArthritis & Rheumatism, 1985